Yale New Haven Health launches RI MOBILE for untethered clinical surveillance

4 March 2020 (Last Updated March 8th, 2020 17:06)

PeraHealth customer Yale New Haven Health (YNHH) has launched Rothman Index Mobile (RI Mobile) for untethered surveillance of patient condition.

Yale New Haven Health launches RI MOBILE for untethered clinical surveillance
RI Mobile platform provide clinicians with the untethered surveillance of patient condition. Credit: Olga Kononenko on Unsplash.

PeraHealth customer Yale New Haven Health (YNHH) has launched Rothman Index Mobile (RI Mobile) for untethered surveillance of patient condition.

RI Mobile platform enables clinicians to access the Rothman Index from their mobile devices. It untethers clinicians from the EMR computer screen and provides remote access to patient surveillance tools that analyse patient trends and alerts.

The device is claimed to help on-the-go clinicians to detect at-risk patients  quickly. Furthermore, it actively sends patient deterioration alerts to clinicians.

Yale New Haven Health has collaborated with PeraHealth for testing and validating new applications of the Rothman Index.

The early implementation of RI Mobile technology is claimed to have provided YNHH greater clinical efficiency by reducing time to respond to patient deterioration.

The Rothman Index is claimed to be the only proven algorithm that derives one simple score from the vast amount of data in the electronic medical record to generate a picture of any patient’s condition over time – despite age, and disease.

It can also detect patient deterioration well in adavance than existing scores and systems, the company stated.

PeraHealth co-founder and CEO Michael Rothman said: “Yale New Haven Health has been a strategic partner and advocate of our technology for many years.”

“We are very pleased to see our RI Mobile technology in the hands of clinicians, allowing them to access critical patient condition information from anywhere in the hospital.”

PeraHealth cited that use of the Rothman Index by YNHH brought positive outcomes including 26% year-over-year mortality reduction, 44% decrease in hospital-acquired sepsis cases, 29% mortality reduction in patients assigned a sepsis DRG.